Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial

Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now presents the full record for the completed Phase II TROPHIMMUN trial of avelumab in chemotherapy-resistant gestational trophoblastic neoplasias, including its design, eligibility criteria, study outcomes, locations, and publications.
    Difference
    48%
    Check dated 2026-11-10T14:58:15.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-03T15:54:01.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A general NIH notice about a terminology transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T15:38:23.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T15:20:10.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Locations and contact information, as well as study record dates and results sections, have been removed. The page now presents a leaner view of the study details with fewer contextual details about where and when the study occurs and its history.
    Difference
    18%
    Check dated 2026-09-22T21:54:44.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.7.0, signaling a version update of the study entry. This change reflects a metadata update rather than a modification to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T21:42:40.000Z thumbnail image

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.